N-type calcium channel and renal injury

Int Urol Nephrol. 2022 Nov;54(11):2871-2879. doi: 10.1007/s11255-022-03183-8. Epub 2022 Apr 13.

Abstract

Accumulating evidences indicated that voltage-gated calcium channels (VDCC), including L-, T-, N-, and P/Q-type, are present in kidney and contribute to renal injury during various chronic diseases trough different mechanisms. As a voltage-gated calcium channel, N-type calcium channel was firstly been founded predominately distributed on nerve endings which control neurotransmitter releases. Since sympathetic nerve is distributed along renal afferent and efferent arterioles, N-type calcium channel blockade on sympathetic nerve terminals would bring renal dynamic improvement by dilating both arterioles and reducing glomerular pressure. In addition, large body of scientific research indicated that neurotransmitters, such as norepinephrine, releases by activating N-type calcium channel can trigger inflammatory and fibrotic signaling pathways in kidney. Interestingly, we recently demonstrated that N-type calcium channel is also expressed on podocytes and may directly contribute to podocyte injury in denervated animal models. In this paper, we will summarize our current knowledge regarding renal N-type calcium channels, and discuss how they might contribute to the river that terminates in renal injury.

Keywords: N-type calcium channel; Podocyte; Renal injury; Sympathetic nerve.

Publication types

  • Review

MeSH terms

  • Animals
  • Calcium
  • Calcium Channel Blockers* / pharmacology
  • Calcium Channel Blockers* / therapeutic use
  • Calcium Channels, L-Type / physiology
  • Calcium Channels, N-Type* / physiology
  • Kidney
  • Neurotransmitter Agents
  • Norepinephrine

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Calcium Channels, N-Type
  • Neurotransmitter Agents
  • Calcium
  • Norepinephrine